Related Experiment Video
Updated: Mar 16, 2026

09:41
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
Published on: July 19, 2019
12.1K
Chronic Traumatic Encephalopathy Pathology in Multiple System Atrophy.
Shunsuke Koga1, Dennis W Dickson1, Kevin F Bieniek2
1Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA(SK, DWD, KFB).
Journal of Neuropathology and Experimental Neurology
|August 21, 2016
Summary
A small percentage of Multiple System Atrophy (MSA) patients showed Chronic Traumatic Encephalopathy (CTE) pathology. This suggests a potential link between these neurodegenerative disorders, even without a history of head trauma.
Area of Science:
- Neuropathology
- Neurodegenerative Diseases
- Brain Injury Research
Background:
- Chronic traumatic encephalopathy (CTE) is linked to repetitive head trauma.
- Multiple system atrophy (MSA) is a neurodegenerative disorder that can involve falls and head trauma.
- The potential for CTE pathology in MSA patients is not well understood.
Purpose of the Study:
- To investigate the prevalence of CTE pathology in individuals with Multiple System Atrophy (MSA).
- To determine if MSA patients can develop CTE pathology, even without a history of contact sports or head trauma.
Main Methods:
- Examined 139 brain bank cases of MSA for CTE pathology using immunohistochemistry with an anti-phospho-tau antibody.
- Further stained sections of basal forebrain and hippocampus for suggestive cases.
- Differentiated CTE from aging-related tau astrogliopathy (ARTAG) using consensus criteria.
Main Results:
- CTE pathology was identified in 8 (6%) of the 139 MSA cases.
- ARTAG pathology was found in 10 (8%) of the MSA cases.
- MSA cases with CTE pathology had a younger median age at death compared to those without CTE or with ARTAG.
Conclusions:
- A subset of Multiple System Atrophy cases exhibit Chronic Traumatic Encephalopathy pathology.
- This finding suggests a potential neuropathological overlap between MSA and CTE.
- CTE pathology can be present in MSA cases irrespective of a documented history of head trauma or contact sports.
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Amyloid Fibrils
12.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.7K

